Home>Cosmetics>

Minoxidil

CAS number: 38304-91-5

Molecular formula: C9H15N5O

molecular weight: 209.25

Chemical structure:

Producers shown on SFDA

(Record date:13/09/2021)

Producer

Documents

GMP Valid till(based on SFDA)

Changzhou Tianhua Pharmaceutical Co., Ltd.

GMP, DMF
Valid till September 2019

Changzhou siyao Pharmaceutical Co., Ltd.

GMP
Valid till February 2019

Tipr Pharmaceutical Co., Ltd.

GMP
Valid till January 2021

Producers shown on EP

(Quoted from EP website;record date:13/09/2021)

Substance
Certificate Holder
Certificate Number
Issue Date
Status
End date
Type
Minoxidil
FLAMMA S.P.A. IT 24040 Chignolo d'Isola
  R1-CEP 2002-212-Rev 05
30/11/2020
VALID
/Chemistry
Minoxidil
Pfizer, Inc. US 10017 New York City
  R1-CEP 2007-015-Rev 00
31/07/2014
WITHDRAWN BY HOLDER
10/09/2020
Chemistry
Minoxidil
KUMAR ORGANIC PRODUCTS LIMITED IN 560 105 Bangalore
  R1-CEP 2013-310-Rev 00
31/05/2021
VALID
/Chemistry
Minoxidil
OLON S.P.A. IT 20053 Rodano
  R1-CEP 1996-003-Rev 08
26/08/2021
VALID
/Chemistry
Minoxidil
VPL CHEMICALS PRIVATE LIMITED IN 562 111 Bangalore rural
  R0-CEP 2018-244-Rev 00
02/01/2020
VALID
/Chemistry


Producer:Changzhou Tianhua Pharmaceutical Co., Ltd., formerly established in 1995, has fixed assets of 80 million yuan and covers an area of 40000 square meters. It only has its own R & D team and has established long-term cooperative relations with well-known universities and scientific research institutions at home and abroad. The company now has more than 70 sets of reactors, GMP API production lines and many sets of high-precision analytical instruments, which can complete a variety of series synthesis reactions such as hydrogenation, Grignard, cyanation and halogenation.


Staff size:1-99 persons


Registered capital:RMB 80 million



Producer:Changzhou siyao Pharmaceutical Co., Ltd. has passed the three management system certification of national drug GMP, international environmental management ISO14001 and international occupational health and safety OHSMS18001, and three products have passed the certification of FDA and CEP of the European Union.

Current production capacity: 25 raw material intermediates, 100 tons, of which 50 tons are self exported; 20 million lyophilized powder needles and 100 million water needles; 2 billion capsules, tablets and controlled and sustained release preparations; 20 million creams and new transdermal patches.

Staff size:400-499 persons

Registered capital:USD 7.08 million



Producer:Tipr Pharmaceutical Co., Ltd.Research Institute was formerly directly under the State Food and drug administration. The pharmaceutical products produced by the company mainly involve antipsychotics, non steroidal anti-inflammatory, analgesia and detoxification, hypoglycemic, antiviral, cardio cerebrovascular and other fields. The dosage forms include small volume injection, tablet, granule, hard capsule, oral liquid and API. All dosage forms have passed GMP certification. It is a designated production unit of national psychotropic drugs and a comprehensive high-tech enterprise.
Staff size:300-399 persons

Registered capital:RMB 50 million



For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +8618402846978